Product Code: ETC4471642 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 |
The Cardiac Marker Testing market in China is experiencing growth due to the rising prevalence of cardiovascular diseases and advancements in diagnostic technologies. Cardiac markers are crucial for the early detection and management of heart-related conditions. The market is driven by increasing health awareness, technological innovations in testing methods, and the expansion of healthcare infrastructure. The growing emphasis on preventive healthcare and the need for accurate diagnostic tools are key factors influencing market growth.
The rising prevalence of cardiovascular diseases and the growing demand for early diagnosis and preventive care are significant drivers of the China Cardiac Marker Testing Market. The increasing awareness about the importance of cardiac health and the availability of advanced testing methods are encouraging more people to undergo regular testing, further propelling market growth.
The China Cardiac Marker Testing market is challenged by high costs associated with advanced diagnostic technologies and limited awareness among the general population regarding cardiac health. Additionally, the market faces regulatory challenges related to the approval and standardization of testing kits. There is also intense competition from alternative diagnostic methods, which can limit market penetration and growth.
To advance the cardiac marker testing market, the Chinese government provides funding for medical research and innovation. Policies focus on improving diagnostic capabilities through subsidies for advanced testing equipment and support for healthcare providers to adopt new technologies. Regulations also ensure that testing procedures meet international quality standards.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cardiac Marker Testing Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 China Cardiac Marker Testing Market - Industry Life Cycle |
3.4 China Cardiac Marker Testing Market - Porter's Five Forces |
3.5 China Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 China Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 China Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 China Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in China |
4.2.2 Growing adoption of advanced diagnostic technologies for cardiac conditions |
4.2.3 Rising awareness about the importance of early detection and treatment of heart diseases |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for cardiac marker testing products |
4.3.2 High cost associated with cardiac marker testing procedures |
4.3.3 Limited access to healthcare facilities in rural areas of China |
5 China Cardiac Marker Testing Market Trends |
6 China Cardiac Marker Testing Market, By Types |
6.1 China Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Cardiac Marker Testing Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 China Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.4 China Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 China Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 China Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 China Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 China Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 China Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 China Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 China Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 China Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 China Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 China Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 China Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 China Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 China Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 China Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 China Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 China Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 China Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 China Cardiac Marker Testing Market Export to Major Countries |
7.2 China Cardiac Marker Testing Market Imports from Major Countries |
8 China Cardiac Marker Testing Market Key Performance Indicators |
8.1 Average turnaround time for cardiac marker test results |
8.2 Adoption rate of novel cardiac marker testing technologies |
8.3 Percentage of population screened for cardiac markers on a regular basis |
9 China Cardiac Marker Testing Market - Opportunity Assessment |
9.1 China Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 China Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 China Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 China Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Cardiac Marker Testing Market - Competitive Landscape |
10.1 China Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 China Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |